Angela Hwang is a member of Pfizer's Executive Team and Group President of the Pfizer Biopharmaceuticals Group, which comprises 80% of Pfizer's revenues. Her organization of 26,000 people brings over 600 innovative medicines and products to patients in more than 125 countries. In 2019, Pfizer Biopharma generated around $40 billion in revenues. As Group President, Angela leads 7 commercial business units delivering medicines that address global health priorities in cancer, rare disease, inflammation & immunology, primary care, infectious diseases, and preventative care with vaccines. In 2019, over 434 million people benefited from a Pfizer Biopharma medicine or vaccine. Angela sits on the Boards of Directors at UPS, EFPIA, as well as the Pfizer Foundation, a charitable organization that addresses global health challenges. In 2019, she was named in Crain's Notable Women in Healthcare list. Angela received her B.S. in Microbiology and Biochemistry from the University of Cape Town and MBA from Cornell University.